Market News & Trends
mPhase Technologies to Pursue Licensing Opportunities for Delivery System
mPhase Technologies, Inc. recently announced that it is pursuing licensing opportunities for its Smart Drug Delivery System. mPhase recently filed a United States Letter Patent…
Starpharma Granted Lucrative Drug Delivery Patents
Starpharma Holdings Ltd recently announced it has been granted three new patents by the United States Patent and Trademark Office (USPTO), which strengthen and expand…
Xenon Exclusively Licenses Merck Compounds
Xenon recently announced that Merck, through an affiliate, has exercised its option to exclusively license small molecule compounds for a novel target for the potential…
Model-Independent Platform Accurately Predicts Drugs’ Stable States to Guide Reformulation for Enhanced Bioavailability
BEND, OR-- Agere Pharmaceuticals, Inc., a leading oral bioavailability contract research and manufacturing organization (CRO/CMO), announced today that it has enhanced the Agere drug delivery…
The New Mega Trends That Will Shape a Future Britain
In the future, 81% of people in the UK will be living in urban areas, there will be 200 million connected devices, and one in…
Unilife Develops Customized Device to Enhance Patient Self-Injection of Biologics
Unilife Corporation recently announced the development of the Unifill Assure, a customized device from its Unifill platform of ready-to-fill (prefilled) syringes that is designed to…
nSpire Health Announces Next-Generation Respiratory Clinical Trial eDiary
nSpire Health Inc. recently announced the introduction of PROLogic(TM), its latest eDiary for respiratory clinical trials. Based on the PiKoLogic(TM) ePRO device platform, PROLogic provides…
Catalent Biologics Expands Into ADCs Through Exclusive License
Catalent Pharma Solutions recently announced it has acquired an exclusive license to market Redwood Bioscience's proprietary SMARTag precision protein-chemical engineering technology for the development of…
Cyclica & Dalton Announce Drug Development Collaboration
Cyclica and Dalton recently announced a collaboration agreement to identify and develop new drug candidates applying advanced computational molecular design to medicinal chemistry and drug…
GSK & A*STAR to Develop New Medicines for Emerging Markets
GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a 5-year strategic agreement to develop new evidence-based formulations (EBFs) specifically for…
Lipid Therapeutics Successfully Files US IND
Lipid Therapeutics recently announced it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed…
BD Announces FDA 510(k) Clearance & Commercial Launch
BD Medical, a segment of BD (Becton, Dickinson and Company) recently announced the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS.…
Aragen Bioscience & Innovent Biologics Announce Collaboration for Biotherapeutic Product Development
Aragen Bioscience, Inc. and Innovent Biologics, Inc. have initiated a collaboration for the development of manufacturing cell lines for biotherapeutic product development. Under the terms…
Foster Expands Nano-Reinforced Polymer Product Range for Medical Devices
Foster Corporation now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight. Nano-reinforced compounds with high…
Hovione Announces a Co-Promotion & Collaboration Agreement
Hovione recently announced a co-promotion and collaboration agreement with Ligand to provide Hovione's customers efficient access to Captisol technology. Captisol, a chemically modified cyclodextrin, is…
Unilife Signs Long-Term Customization & Commercial Supply Agreement; $110-Million Potential
Unilife Corporation recently announced the signing of a Customization and Commercial Supply Agreement with a US pharmaceutical company for the EZMixTM dual-chamber syringe. Unilife will…
US Nanotechnology Drug Delivery Market Forecast to Grow Significantly Through 2016
Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine…
Vetter's New Commercial Filling Line Ready for cGMP Filling
Vetter recently announced that its new award-winning filling line at the company's Ravensburg Vetter South facility is fully validated and ready for cGMP filling, after…
Aastrom Biosciences Announces Strategic Change in R&D Programs
Aastrom Biosciences, Inc. recently announced a strategic change in its research and development programs to focus on the clinical development of its lead product, ixmyelocel-T,…
Biodel Completes Phase II Enrollment in Clinical Trial of Ultra-Rapid-Acting Insulin
Biodel Inc. recently announced the completion of patient enrollment in a Phase II clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of…
